A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 209,146 shares of VCYT stock, worth $8.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
209,146
Previous 239,574 12.7%
Holding current value
$8.28 Million
Previous $5.19 Million 37.1%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.0 - $35.25 $638,988 - $1.07 Million
-30,428 Reduced 12.7%
209,146 $7.12 Million
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $4.52 Million - $5.64 Million
239,574 New
239,574 $5.19 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.83B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.